Lack of Selective Vulnerability to Anticholinergic Induced Cognitive Impairment in Early Parkinson’s Disease

Thirteen patients with idiopathic Parkinson's disease of recent onset (mean age 63·2 years) and a group of 10 young healthy volunteers (mean age 26·1 years) underwent a series of neuropsychological tests for assessment of memory, learning ability and mental processing speed before and during tr...

Full description

Bibliographic Details
Main Authors: L. Schelosky, Th. Benke, W. Poewe
Format: Article
Language:English
Published: Hindawi Limited 1991-01-01
Series:Behavioural Neurology
Online Access:http://dx.doi.org/10.3233/BEN-1991-4206
Description
Summary:Thirteen patients with idiopathic Parkinson's disease of recent onset (mean age 63·2 years) and a group of 10 young healthy volunteers (mean age 26·1 years) underwent a series of neuropsychological tests for assessment of memory, learning ability and mental processing speed before and during treatment with trihexyphenidyl. Retesting after anticholinergic exposure (mean of 2 weeks for patients and 1 week for controls) revealed in young healthy controls the same pattern and magnitude of decline in memory function as in Parkinson patients. Non-demented subjects with Parkinson's disease of recent onset thus do riot seem to be selectively vulnerable to cognitive side-effects of anticholinergic treatment.
ISSN:0953-4180
1875-8584